2 weeks Eton Pharmaceuticals, Inc. (ETON) Reports Q4 Loss, Tops Revenue Estimates Zacks
Eton Pharmaceuticals (ETON) delivered earnings and revenue surprises of 0% and 9.05%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
X